Replies to post #249 on KalVista Pharmaceuticals (KALV)

[Global Interface]

That is true that the 81-19% is on a fully-diluted basis. 100m authorized and 26m OS.

What I want to know is what they are bringing to the table given existing stockholder equity is something like $40m.